Published in Am J Gastroenterol on September 24, 2013
Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility. Microbiome (2014) 1.82
The Indications, Applications, and Risks of Proton Pump Inhibitors. Dtsch Arztebl Int (2016) 1.45
Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review. PLoS One (2014) 1.23
Aggression of C-difficile infections in PPI consumers. Am J Gastroenterol (2014) 1.06
Re: proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients. Am J Gastroenterol (2014) 1.06
The impact of proton pump inhibitors on the human gastrointestinal microbiome. Clin Lab Med (2014) 0.97
Interactions Between the Gastrointestinal Microbiome and Clostridium difficile. Annu Rev Microbiol (2015) 0.93
Recurrent Clostridium difficile infection and the microbiome. J Gastroenterol (2015) 0.80
A prediction model for Clostridium difficile recurrence. J Community Hosp Intern Med Perspect (2015) 0.80
Two-week treatment with proton pump inhibitor is sufficient for healing post endoscopic submucosal dissection ulcers. World J Gastroenterol (2014) 0.79
Recurrence and death after Clostridium difficile infection: gender-dependant influence of proton pump inhibitor therapy. Springerplus (2016) 0.79
Proton Pump Inhibitors Do Not Increase Risk for Clostridium difficile Infection in the Intensive Care Unit. Am J Gastroenterol (2016) 0.79
Response to Abdallah et al. Am J Gastroenterol (2014) 0.75
Proton pump inhibitors for the treatment of patients with erosive esophagitis and gastroesophageal reflux disease: current evidence and safety of dexlansoprazole. Clin Exp Gastroenterol (2016) 0.75
The emerging metabolic view of Clostridium difficile pathogenesis. Curr Opin Microbiol (2016) 0.75
Response to Daniell. Am J Gastroenterol (2014) 0.75
Acid suppression medications and bacterial gastroenteritis: a population-based cohort study. Br J Clin Pharmacol (2017) 0.75
Editorial: PPIs and recurrent C. difficile infection: no association? Am J Gastroenterol (2013) 0.75
Clostridium difficile infection health disparities by race among hospitalized adults in the United States, 2001 to 2010. BMC Infect Dis (2016) 0.75
Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis. JAMA Intern Med (2017) 0.75
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis (1987) 174.79
Unlocking clinical data from narrative reports: a study of natural language processing. Ann Intern Med (1995) 14.15
Clostridium difficile--more difficult than ever. N Engl J Med (2008) 12.12
Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol (2013) 7.81
Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis (2005) 7.16
Clinical practice. Antibiotic-associated diarrhea. N Engl J Med (2002) 7.13
Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA (2005) 6.87
Automated identification of postoperative complications within an electronic medical record using natural language processing. JAMA (2011) 5.40
Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol (2012) 5.06
The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol (2011) 3.92
Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study. Clin Infect Dis (2009) 3.86
Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis. Am J Gastroenterol (2012) 3.59
Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS One (2010) 3.45
Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea. Clin Infect Dis (2007) 3.24
Accuracy of computerized outpatient diagnoses in a Veterans Affairs general medicine clinic. Am J Manag Care (2002) 2.97
Proton pump inhibitors and risk for recurrent Clostridium difficile infection. Arch Intern Med (2010) 2.71
Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med (2010) 2.55
Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. Clin Infect Dis (1997) 2.53
Shifting the balance: antibiotic effects on host-microbiota mutualism. Nat Rev Microbiol (2011) 2.43
Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. J Hosp Infect (2008) 2.30
Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. Clin Infect Dis (1996) 2.04
Clostridium difficile colitis: factors influencing treatment failure and relapse--a prospective evaluation. Am J Gastroenterol (1998) 1.95
Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. CMAJ (2008) 1.91
Overutilization of proton pump inhibitors: a review of cost-effectiveness and risk [corrected]. Am J Gastroenterol (2009) 1.74
Recurrent clostridium difficile. Gastroenterology (2006) 1.73
Comparison of a commercial multiplex real-time PCR to the cell cytotoxicity neutralization assay for diagnosis of clostridium difficile infections. J Clin Microbiol (2009) 1.67
Clinician attitudes toward and use of electronic problem lists: a thematic analysis. BMC Med Inform Decis Mak (2011) 1.65
Comparative metagenomic study of alterations to the intestinal microbiota and risk of nosocomial Clostridum difficile-associated disease. J Infect Dis (2010) 1.62
Population dynamics of ingested Clostridium difficile in the gastrointestinal tract of the Syrian hamster. J Infect Dis (1985) 1.44
Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. J Antimicrob Chemother (2011) 1.39
A comparison of the Charlson comorbidities derived from medical language processing and administrative data. Proc AMIA Symp (2002) 1.38
Safety of proton pump inhibitor exposure. Gastroenterology (2010) 1.37
Who is using chronic acid suppression therapy and why? Am J Gastroenterol (2003) 1.34
Proton pump inhibitors as a risk factor for recurrence of Clostridium-difficile-associated diarrhea. World J Gastroenterol (2010) 1.31
Effect of the proton pump inhibitor omeprazole on the gastrointestinal bacterial microbiota of healthy dogs. FEMS Microbiol Ecol (2012) 1.21
Association of proton-pump inhibitors with outcomes in Clostridium difficile colitis. Am J Health Syst Pharm (2007) 1.18
In vitro killing of nosocomial pathogens by acid and acidified nitrite. Antimicrob Agents Chemother (2006) 1.14
Frequent hospital readmissions for Clostridium difficile infection and the impact on estimates of hospital-associated C. difficile burden. Infect Control Hosp Epidemiol (2011) 1.07
Does doxycycline protect against development of Clostridium difficile infection? Clin Infect Dis (2012) 1.06
Risk factors for recurrence of Clostridium difficile-associated diarrhea in the elderly. Scand J Infect Dis (2002) 1.04
Reported side effects and complications of long-term proton pump inhibitor use: dissecting the evidence. Clin Gastroenterol Hepatol (2012) 1.03
Deriving comorbidities from medical records using natural language processing. J Am Med Inform Assoc (2013) 0.99
Diabetes mellitus as a risk factor for recurrence of Clostridium difficile infection in the acute care hospital setting. Am J Infect Control (2011) 0.93
How much do PPIs contribute to C. difficile infections? Am J Gastroenterol (2012) 0.91
Clostridium difficile of the ileum following total abdominal colectomy, with or without proctectomy: who is at risk? Dis Colon Rectum (2012) 0.89
An automated tool for detecting medication overuse based on the electronic health records. Pharmacoepidemiol Drug Saf (2012) 0.88
Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst (2005) 8.36
Use of natural language processing to translate clinical information from a database of 889,921 chest radiographic reports. Radiology (2002) 5.52
GeneWays: a system for extracting, analyzing, visualizing, and integrating molecular pathway data. J Biomed Inform (2004) 4.57
Automatic resolution of ambiguous terms based on machine learning and conceptual relations in the UMLS. J Am Med Inform Assoc (2002) 4.24
Active computerized pharmacovigilance using natural language processing, statistics, and electronic health records: a feasibility study. J Am Med Inform Assoc (2009) 3.62
Mapping abbreviations to full forms in biomedical articles. J Am Med Inform Assoc (2002) 3.29
Automated acquisition of disease drug knowledge from biomedical and clinical documents: an initial study. J Am Med Inform Assoc (2007) 3.09
Comparing ICD9-encoded diagnoses and NLP-processed discharge summaries for clinical trials pre-screening: a case study. AMIA Annu Symp Proc (2008) 3.00
System architecture for temporal information extraction, representation and reasoning in clinical narrative reports. AMIA Annu Symp Proc (2005) 2.93
Gene name ambiguity of eukaryotic nomenclatures. Bioinformatics (2004) 2.72
A multi-aspect comparison study of supervised word sense disambiguation. J Am Med Inform Assoc (2004) 2.67
Real-time increased detection of neoplastic tissue in Barrett's esophagus with probe-based confocal laser endomicroscopy: final results of an international multicenter, prospective, randomized, controlled trial. Gastrointest Endosc (2011) 2.51
A study of abbreviations in clinical notes. AMIA Annu Symp Proc (2007) 2.48
Extracting information on pneumonia in infants using natural language processing of radiology reports. J Biomed Inform (2005) 2.48
A study of abbreviations in MEDLINE abstracts. Proc AMIA Symp (2002) 2.44
Extracting phenotypic information from the literature via natural language processing. Stud Health Technol Inform (2004) 2.36
Facilitating cancer research using natural language processing of pathology reports. Stud Health Technol Inform (2004) 2.28
Safety and efficacy of endoscopic spray cryotherapy for Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc (2010) 2.28
Mining multi-item drug adverse effect associations in spontaneous reporting systems. BMC Bioinformatics (2010) 2.17
Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia. Cancer Cell (2012) 2.16
Exploiting semantic relations for literature-based discovery. AMIA Annu Symp Proc (2006) 2.15
Information theory applied to the sparse gene ontology annotation network to predict novel gene function. Bioinformatics (2007) 2.15
Gene symbol disambiguation using knowledge-based profiles. Bioinformatics (2007) 2.13
Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Ann Surg Oncol (2011) 2.10
Cancer mortality surveillance--United States, 1990-2000. MMWR Surveill Summ (2004) 1.94
Colorectal cancer in U.S. adults younger than 50 years of age, 1998-2001. Cancer (2006) 1.94
Machine learning and word sense disambiguation in the biomedical domain: design and evaluation issues. BMC Bioinformatics (2006) 1.93
Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett's esophagus: results from a US Multicenter Consortium. Gastroenterology (2013) 1.92
Information Visualization Techniques in Bioinformatics during the Postgenomic Era. Drug Discov Today Biosilico (2004) 1.85
Endoscopic spray cryotherapy for esophageal cancer: safety and efficacy. Gastrointest Endosc (2010) 1.79
PhenoGO: assigning phenotypic context to gene ontology annotations with natural language processing. Pac Symp Biocomput (2006) 1.76
A jumpstart for student researchers in Iran. Lancet (2007) 1.74
Syndromic surveillance using ambulatory electronic health records. J Am Med Inform Assoc (2009) 1.64
Combing signals from spontaneous reports and electronic health records for detection of adverse drug reactions. J Am Med Inform Assoc (2012) 1.60
Of truth and pathways: chasing bits of information through myriads of articles. Bioinformatics (2002) 1.56
Automatic extraction of gene and protein synonyms from MEDLINE and journal articles. Proc AMIA Symp (2002) 1.55
National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003. Prev Chronic Dis (2008) 1.55
Folic acid increases global DNA methylation and reduces inflammation to prevent Helicobacter-associated gastric cancer in mice. Gastroenterology (2012) 1.54
Investigation of postoperative allograft-associated infections in patients who underwent musculoskeletal allograft implantation. Clin Infect Dis (2005) 1.53
Mining terminological knowledge in large biomedical corpora. Pac Symp Biocomput (2003) 1.52
Descriptive epidemiology of colorectal cancer in the United States, 1998-2001. Cancer (2006) 1.46
Facilitating adverse drug event detection in pharmacovigilance databases using molecular structure similarity: application to rhabdomyolysis. J Am Med Inform Assoc (2011) 1.44
Comparison of endoscopic and clinical characteristics of patients with familial and sporadic Barrett's esophagus. Dig Dis Sci (2011) 1.43
Facilitating research in pathology using natural language processing. AMIA Annu Symp Proc (2003) 1.42
A comparison of the Charlson comorbidities derived from medical language processing and administrative data. Proc AMIA Symp (2002) 1.38
Detection of intestinal metaplasia after successful eradication of Barrett's Esophagus with radiofrequency ablation. Dig Dis Sci (2011) 1.36
Semantic classification of biomedical concepts using distributional similarity. J Am Med Inform Assoc (2007) 1.35
Statistical Mining of Potential Drug Interaction Adverse Effects in FDA's Spontaneous Reporting System. AMIA Annu Symp Proc (2010) 1.34
CliniViewer: a tool for viewing electronic medical records based on natural language processing and XML. Stud Health Technol Inform (2004) 1.33
Does confounding explain the association between PPIs and Clostridium difficile-related diarrhea? Am J Gastroenterol (2013) 1.32
Discovering disease associations by integrating electronic clinical data and medical literature. PLoS One (2011) 1.32
Safety, tolerability, and efficacy of endoscopic low-pressure liquid nitrogen spray cryotherapy in the esophagus. Dis Esophagus (2009) 1.32
A drug-adverse event extraction algorithm to support pharmacovigilance knowledge mining from PubMed citations. AMIA Annu Symp Proc (2011) 1.31
Word sense disambiguation via semantic type classification. AMIA Annu Symp Proc (2008) 1.30
ISO reference terminology models for nursing: applicability for natural language processing of nursing narratives. Int J Med Inform (2005) 1.30
Discovery of protein interaction networks shared by diseases. Pac Symp Biocomput (2007) 1.30
Drug-drug interaction through molecular structure similarity analysis. J Am Med Inform Assoc (2012) 1.25
Methods for building sense inventories of abbreviations in clinical notes. J Am Med Inform Assoc (2008) 1.24
Human and automated coding of rehabilitation discharge summaries according to the International Classification of Functioning, Disability, and Health. J Am Med Inform Assoc (2006) 1.23
Generating executable knowledge for evidence-based medicine using natural language and semantic processing. AMIA Annu Symp Proc (2006) 1.20
A comparison of semantic categories of the ISO reference terminology models for nursing and the MedLEE natural language processing system. Stud Health Technol Inform (2004) 1.19
Use of computerized surveillance to detect nosocomial pneumonia in neonatal intensive care unit patients. Am J Infect Control (2005) 1.19
Quantitative assessment of dictionary-based protein named entity tagging. J Am Med Inform Assoc (2006) 1.19
Characterizing environmental and phenotypic associations using information theory and electronic health records. BMC Bioinformatics (2009) 1.16
A collaborative approach to developing an electronic health record phenotyping algorithm for drug-induced liver injury. J Am Med Inform Assoc (2013) 1.14
Effect of the frequency of delivery of reminders and an influenza tool kit on increasing influenza vaccination rates among adults with high-risk conditions. Am J Manag Care (2004) 1.11
Promoting development and use of systematic reviews in a developing country. J Eval Clin Pract (2009) 1.11
Detection of practice pattern trends through Natural Language Processing of clinical narratives and biomedical literature. AMIA Annu Symp Proc (2007) 1.10
Natural language processing challenges in HIV/AIDS clinic notes. AMIA Annu Symp Proc (2003) 1.08
Representing nested semantic information in a linear string of text using XML. Proc AMIA Symp (2002) 1.07
Using contextual and lexical features to restructure and validate the classification of biomedical concepts. BMC Bioinformatics (2007) 1.07
Does health insurance coverage of office visits influence colorectal cancer testing? Cancer Epidemiol Biomarkers Prev (2005) 1.03
Selecting information in electronic health records for knowledge acquisition. J Biomed Inform (2010) 1.03
PhenoGO: an integrated resource for the multiscale mining of clinical and biological data. BMC Bioinformatics (2009) 1.01
The influence of year-end bonuses on colorectal cancer screening. Am J Manag Care (2004) 1.01
Automated knowledge acquisition from clinical narrative reports. AMIA Annu Symp Proc (2008) 1.00
Factors influencing editors' decision on acceptance or rejection of manuscripts: the authors' perspective. Arch Iran Med (2008) 1.00
Rectal leiomyosarcoma after pelvic irradiation. Clin Gastroenterol Hepatol (2012) 1.00
Combining corpus-derived sense profiles with estimated frequency information to disambiguate clinical abbreviations. AMIA Annu Symp Proc (2012) 0.99
Deriving comorbidities from medical records using natural language processing. J Am Med Inform Assoc (2013) 0.99
Probabilistic inference of molecular networks from noisy data sources. Bioinformatics (2004) 0.98
Visualizing information across multidimensional post-genomic structured and textual databases. Bioinformatics (2004) 0.96
Integrating heterogeneous knowledge sources to acquire executable drug-related knowledge. AMIA Annu Symp Proc (2010) 0.96
Enhancing adverse drug event detection in electronic health records using molecular structure similarity: application to pancreatitis. PLoS One (2012) 0.95
Detection of drug-drug interactions by modeling interaction profile fingerprints. PLoS One (2013) 0.95
Disseminating natural language processed clinical narratives. AMIA Annu Symp Proc (2006) 0.95
A method for controlling complex confounding effects in the detection of adverse drug reactions using electronic health records. J Am Med Inform Assoc (2013) 0.95
Leukocyte adhesion deficiency type 1 presenting as leukemoid reaction. Indian J Pediatr (2007) 0.95
Determining the reasons for medication prescriptions in the EHR using knowledge and natural language processing. AMIA Annu Symp Proc (2011) 0.94
Barrett's esophagus: endoscopic treatments II. Ann N Y Acad Sci (2011) 0.92
Semantic reclassification of the UMLS concepts. Bioinformatics (2008) 0.92
Use of adjuvant 5-fluorouracil and radiation therapy after gastric cancer resection among the elderly and impact on survival. Int J Radiat Oncol Biol Phys (2009) 0.91
Barrett esophagus: what a mouse model can teach us about human disease. Cell Cycle (2012) 0.90
A natural language processing (NLP) tool to assist in the curation of the laboratory Mouse Tumor Biology Database. AMIA Annu Symp Proc (2006) 0.89
Natural language processing and visualization in the molecular imaging domain. J Biomed Inform (2006) 0.89
An automated tool for detecting medication overuse based on the electronic health records. Pharmacoepidemiol Drug Saf (2012) 0.88